Facility Management, Maintenance and Operations Core

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 1UC7AI180255-01

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2023
    2028
  • Known Financial Commitments (USD)

    $1,401,116
  • Funder

    National Institutes of Health (NIH)
  • Principal Investigator

    ASSISTANT PROFESSOR Sixto Leal
  • Research Location

    United States of America
  • Lead Research Institution

    UNIVERSITY OF ALABAMA AT BIRMINGHAM
  • Research Priority Alignment

    N/A
  • Research Category

    Health Systems Research

  • Research Subcategory

    Medicines, vaccines & other technologies

  • Special Interest Tags

    N/A

  • Study Type

    Not applicable

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Project Summary/Abstract: Core 1 of this UC7 proposal outlines a strategic plan for operational support, personnel support, and replacement of essential basic scientific equipment within the UAB Southeastern Biosafety Laboratory, Alabama Birmingham (SEBLAB). Investment in the UAB SEBLAB advances the UAB and NIAID mission to bring together innovative research technology, infectious disease models, and dedicated staff to make novel discoveries on the pathogenesis, detection, treatment and control of emerging infectious diseases. Aim 1 outlines facility maintenance and operational support required for SEBLAB to foster safe and productive high containment research programs. Aim 2 highlights critical support needed for highly trained and skilled personnel to safely and effectively operate this high complexity facility. Aim 3 outlines essential basic scientific equipment in need of repair/replacement to maintain high quality research productivity. Upon completion, this project will achieve the following: 1) Support SEBLAB facility operational expenses; 2) Fund the leadership, administrative, and technical staff involved in SEBLAB operations, and 3) Replace existing basic scientific equipment needed to execute groundbreaking research on high containment pathogens.